New Reference: Trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer
|New Reference: Trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer|
Lancet Oncol, 20 APR, 2023
Andre F et al. Trastuzumab deruxtecan versus treatment of physician’s choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomized, open-label, multicentre, phase 3 trial,
Reviewed by Elvin CHALABİYEV, MD on MAY 10, 2023
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.